Showing results (101-110 of 114) with videos related to
Sort By:
Pageof 12
Bone Marrow Transplantation|November 18, 2023
Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantationAlexandros Spyridonidis, Myriam Labopin, Tobias Gedde-Dahl, et al.Leukemia|October 21, 2020
A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapyEva M Weissinger, Jochen Metzger, Michael Schleuning, et al.Haematologica|January 29, 2026
GVHD and GRFS in patients with acute myeloid leukemia undergoing allogeneic HCT with treosulfan- versus reduced-intensity busulfan-based conditioning: a subgroup analysis of a randomized phase 3 trialFriedrich Stölzel, Matthias Stelljes, Dietrich Wilhelm Beelen, et al.Frontiers in Immunology|April 17, 2024
Donor KIR genotype based outcome prediction after allogeneic stem cell transplantation: no land in sightJohannes Schetelig, Henning Baldauf, Falk Heidenreich, et al.American Journal of Hematology|May 26, 2022
Treosulfan compared with reduced-intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trialDietrich W Beelen, Matthias Stelljes, Péter Reményi, et al.The Lancet. Haematology|April 7, 2024
Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trialMatthias Stelljes, Jan Moritz Middeke, Gesine Bug, et al.Blood|July 30, 2025
Disease risk but not remission status determines transplant outcomes in AML: long-term outcomes of the ASAP trialMatthias Stelljes, Jan Moritz Middeke, Gesine Bug, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2020
Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3-Internal Tandem Duplication Mutation (SORMAIN)Andreas Burchert, Gesine Bug, Lea V Fritz, et al.The British Journal of Psychiatry : the Journal of Mental Science|June 27, 2025
Effectiveness of peer support for people with severe mental health conditions in high-, middle- and low-income countries: multicentre randomised controlled trialBernd Puschner, Juliet Nakku, Ramona Hiltensperger, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2014
Hematopoietic stem-cell transplantation for advanced systemic mastocytosisCelalettin Ustun, Andreas Reiter, Bart L Scott, et al.Pageof 12